ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 70 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 4.69 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $16,000 | -84.3% | 12,777 | -84.8% | 0.00% | -100.0% |
| Q2 2020 | $102,000 | +21.4% | 84,329 | +113.0% | 0.00% | – |
| Q4 2019 | $84,000 | +47.4% | 39,588 | +140.9% | 0.00% | -100.0% |
| Q1 2019 | $57,000 | +72.7% | 16,433 | +1.4% | 0.00% | 0.0% |
| Q4 2017 | $33,000 | -81.8% | 16,200 | -58.9% | 0.00% | -66.7% |
| Q3 2017 | $181,000 | +39.2% | 39,375 | +16.5% | 0.00% | -78.6% |
| Q4 2015 | $130,000 | – | 33,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| LINCOLN CAPITAL CORP | 34,250 | $116,000 | 0.11% |
| Kovack Advisors, Inc. | 24,393 | $82,000 | 0.02% |
| Cedar Wealth Management, LLC | 12,000 | $41,000 | 0.02% |
| Ausdal Financial Partners, Inc. | 19,590 | $66,000 | 0.02% |
| HRT FINANCIAL LP | 15,990 | $53,000 | 0.02% |
| Granite Investment Partners, LLC | 53,853 | $182,000 | 0.01% |
| Joel Isaacson & Co., LLC | 20,000 | $68,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 53,658 | $181,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 246,150 | $831,000 | 0.01% |
| Dynamic Technology Lab Private Ltd | 15,108 | $51,000 | 0.01% |